Skip to main content
Erschienen in: AIDS and Behavior 3/2015

01.03.2015 | Original Paper

Uptake of HIV Testing in Substance Use Disorder Treatment Programs That Offer On-Site Testing

verfasst von: Tiffany L. Kyle, Viviana E. Horigian, Susan Tross, Valerie A. Gruber, Margaret Pereyra, Raul N. Mandler, Daniel J. Feaster, Lisa R. Metsch

Erschienen in: AIDS and Behavior | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Increasing rates of HIV testing within substance use disorder (SUD) treatment clients is an important public health strategy for reducing HIV transmission rates. The present study examined uptake of HIV testing among 1,224 clients in five SUD treatment units that offered on-site testing in Florida, New York, and California. Nearly one-third (30 %) of the participants, who had not previously tested positive, reported not having been tested for HIV within the past 12 months. Women, African Americans, and injection drug users had a higher likelihood of having been tested within the past 12 months. The SUD treatment program was the most frequently identified location of participants’ last HIV test. Despite the availability of free, on-site testing, a substantial proportion of clients were not tested, suggesting that strategies to increase uptake of testing should include addressing barriers not limited to location and cost.
Literatur
2.
Zurück zum Zitat Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.CrossRefPubMed Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.CrossRefPubMed
3.
4.
Zurück zum Zitat Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010;50(3):85–95.CrossRef Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010;50(3):85–95.CrossRef
5.
Zurück zum Zitat Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(RR-14):1–17. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(RR-14):1–17.
6.
Zurück zum Zitat Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893–6.CrossRefPubMed Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893–6.CrossRefPubMed
7.
Zurück zum Zitat Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas—2010. HIV Surveillance Supplemental Report 2012;17(3), part A. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas—2010. HIV Surveillance Supplemental Report 2012;17(3), part A.
8.
Zurück zum Zitat Centers for Disease Control and Prevention. Diagnoses of HIV infection and AIDS in the United States and dependent areas, 2009. HIV Surveillance Report 2010, 21. Centers for Disease Control and Prevention. Diagnoses of HIV infection and AIDS in the United States and dependent areas, 2009. HIV Surveillance Report 2010, 21.
9.
Zurück zum Zitat King KM, Nguyen HV, Kosterman R, Bailey JA, Hawkins JD. Co-occurrence of sexual risk behaviors and substance use across emerging adulthood: evidence for state- and trait-level associations. Addiction. 2012;107(7):1288–96.CrossRefPubMedCentralPubMed King KM, Nguyen HV, Kosterman R, Bailey JA, Hawkins JD. Co-occurrence of sexual risk behaviors and substance use across emerging adulthood: evidence for state- and trait-level associations. Addiction. 2012;107(7):1288–96.CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Raj A, Saitz R, Cheng DM. Associations between alcohol, heroin and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse. 2007;33:169–78.CrossRefPubMed Raj A, Saitz R, Cheng DM. Associations between alcohol, heroin and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse. 2007;33:169–78.CrossRefPubMed
11.
Zurück zum Zitat Rosengard C, Anderson BJ, Stein MD. Correlates of condom use and reasons for condom non-use among drug users. Am J Drug Alcohol Abuse. 2006;32:637–44.CrossRefPubMed Rosengard C, Anderson BJ, Stein MD. Correlates of condom use and reasons for condom non-use among drug users. Am J Drug Alcohol Abuse. 2006;32:637–44.CrossRefPubMed
12.
Zurück zum Zitat Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012;102(6):1160–7.CrossRefPubMedCentralPubMed Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012;102(6):1160–7.CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Abraham AJ, O’Brien LA, Bride BE, Roman PM. HIV/AIDS services in private substance abuse treatment programs. Drug Alcohol Depend. 2011;115(1–2):16–22.CrossRefPubMedCentralPubMed Abraham AJ, O’Brien LA, Bride BE, Roman PM. HIV/AIDS services in private substance abuse treatment programs. Drug Alcohol Depend. 2011;115(1–2):16–22.CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Abraham AJ, O’Brien LA, Knudsen HK, Bride BE, Smith GR, Roman PM. Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs. J Subst Abuse Treat. 2012;44(1):120–5.CrossRefPubMedCentralPubMed Abraham AJ, O’Brien LA, Knudsen HK, Bride BE, Smith GR, Roman PM. Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs. J Subst Abuse Treat. 2012;44(1):120–5.CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Pollack HA, D’Aunno T. HIV testing and counseling in the nation’s outpatient substance abuse treatment system, 1995–2005. J Subst Abuse Treat. 2010;38(4):307–16.CrossRefPubMed Pollack HA, D’Aunno T. HIV testing and counseling in the nation’s outpatient substance abuse treatment system, 1995–2005. J Subst Abuse Treat. 2010;38(4):307–16.CrossRefPubMed
16.
Zurück zum Zitat Brown LS Jr, Kritz SA, Goldsmith RJ, et al. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2006;30(4):315–21.CrossRefPubMedCentralPubMed Brown LS Jr, Kritz SA, Goldsmith RJ, et al. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2006;30(4):315–21.CrossRefPubMedCentralPubMed
17.
Zurück zum Zitat D’Aunno T, Pollack HA, Jiang L, Metsch LR, Friedmann PD. HIV testing in the nation’s opioid treatment programs, 2005–2011: the role of state regulations. Health Serv Res. 2014;49:230–48.CrossRefPubMedCentralPubMed D’Aunno T, Pollack HA, Jiang L, Metsch LR, Friedmann PD. HIV testing in the nation’s opioid treatment programs, 2005–2011: the role of state regulations. Health Serv Res. 2014;49:230–48.CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Heimer R, Grau LE, Curtin E, Khoshnood K, Singer M. Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts. Am J Public Health. 2007;97(1):110–6.CrossRefPubMedCentralPubMed Heimer R, Grau LE, Curtin E, Khoshnood K, Singer M. Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts. Am J Public Health. 2007;97(1):110–6.CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat National Institute of Alcohol Abuse and Alcoholism. NIAAA council approves definition of binge drinking. NIAAA Newslett 2004;3:3. National Institute of Alcohol Abuse and Alcoholism. NIAAA council approves definition of binge drinking. NIAAA Newslett 2004;3:3.
20.
Zurück zum Zitat Petroll AE, DiFranceisco W, McAuliffe TL, Seal DW, Kelly JA, Pinkerton SD. HIV testing rates, testing locations, and healthcare utilization among urban African-American men. J Urban Health. 2008;86(1):119–31.CrossRefPubMedCentralPubMed Petroll AE, DiFranceisco W, McAuliffe TL, Seal DW, Kelly JA, Pinkerton SD. HIV testing rates, testing locations, and healthcare utilization among urban African-American men. J Urban Health. 2008;86(1):119–31.CrossRefPubMedCentralPubMed
21.
Zurück zum Zitat Schackman BR, Metsch LR, Colfax GN. The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial. Drug Alcohol Depend. 2012;128(1–2):90–7.PubMedCentralPubMed Schackman BR, Metsch LR, Colfax GN. The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial. Drug Alcohol Depend. 2012;128(1–2):90–7.PubMedCentralPubMed
22.
Zurück zum Zitat Farnham PG, Holtgrave DR, Sansom SL, Hall HI. Medical costs averted by HIV prevention efforts in the United States, 1991–2006. J Acquir Immune Defic Syndr. 2010;54:565–7.CrossRefPubMed Farnham PG, Holtgrave DR, Sansom SL, Hall HI. Medical costs averted by HIV prevention efforts in the United States, 1991–2006. J Acquir Immune Defic Syndr. 2010;54:565–7.CrossRefPubMed
23.
Zurück zum Zitat Jain S, Loman ES, Kessler A, et al. Seroprevalence study using oral rapid HIV testing in a large urban emergency department. J Emerg Med. 2012;43(5):269–75.CrossRef Jain S, Loman ES, Kessler A, et al. Seroprevalence study using oral rapid HIV testing in a large urban emergency department. J Emerg Med. 2012;43(5):269–75.CrossRef
24.
Zurück zum Zitat Cunningham CO, Doran B, DeLuca J, Dyksterhouse R, Asgary R, Sacajiu G. Routine opt-out HIV testing in an urban community health center. AIDS Patient Care STDS. 2009;23(8):619–23.CrossRefPubMedCentralPubMed Cunningham CO, Doran B, DeLuca J, Dyksterhouse R, Asgary R, Sacajiu G. Routine opt-out HIV testing in an urban community health center. AIDS Patient Care STDS. 2009;23(8):619–23.CrossRefPubMedCentralPubMed
25.
Zurück zum Zitat Christopoulos KA, Weiser SD, Koester KA, et al. Understanding patient acceptance and refusal of HIV testing in the emergency department. BMC Public Health. 2012;3(12):3.CrossRef Christopoulos KA, Weiser SD, Koester KA, et al. Understanding patient acceptance and refusal of HIV testing in the emergency department. BMC Public Health. 2012;3(12):3.CrossRef
27.
Zurück zum Zitat Haynes LF, Calsyn DA, Tross S. Addressing sexual issues in addictions treatment. Counselor. 2008;9(4):28–36. Haynes LF, Calsyn DA, Tross S. Addressing sexual issues in addictions treatment. Counselor. 2008;9(4):28–36.
28.
Zurück zum Zitat Pope K, Sonne J, Greene B. What therapists don’t talk about and why understanding taboos that hurt us and our clients. Washington, DC: American Psychological Association; 2006.CrossRef Pope K, Sonne J, Greene B. What therapists don’t talk about and why understanding taboos that hurt us and our clients. Washington, DC: American Psychological Association; 2006.CrossRef
Metadaten
Titel
Uptake of HIV Testing in Substance Use Disorder Treatment Programs That Offer On-Site Testing
verfasst von
Tiffany L. Kyle
Viviana E. Horigian
Susan Tross
Valerie A. Gruber
Margaret Pereyra
Raul N. Mandler
Daniel J. Feaster
Lisa R. Metsch
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 3/2015
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0864-2

Weitere Artikel der Ausgabe 3/2015

AIDS and Behavior 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.